Generics

(Image: Getty/marchmeena29)

Amneal invests $340m in generics distributor

By Vassia Barba

Amneal announces acquisition of 65.1% majority interest of generics distributing company, AvKARE, boosting its presence in the generics and federal healthcare market.

(Image: Getty/Elen11)

The scale of generic uptake in the major markets

By Ben Hargreaves

The divergence across global market penetration of generic medicines is broad, with some countries’ markets worth close to half of the entire sector or as low as one fifth, according to IGBA.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All